The Acorda Therapeutics Inc (ACOR) Given Average Rating of "Buy" by Analysts

Xavier Trudeau
Juin 19, 2017

Following the completion of the sale, the insider now directly owns 46,123 shares in the company, valued at approximately $726,437.25.

Midstates Petroleum Company, Inc. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company.

Acorda Therapeutics, Inc., launched on March 17, 1995, is a biopharmaceutical company. Its down 9.71% from 6.09 million shares, reported previously. Its revenue totaled $127.33 million down -9.46% from the previous quarter. The company has market cap of $801.34 million. The stock rose 0.58% or $0.1 reaching $17.2.

About 527,356 shares traded.

Acorda Therapeutics (NASDAQ:ACOR) last issued its quarterly earnings data on Thursday, April 27th. It has underperformed by 57.38% the S&P500.

Among 17 analysts covering Williams Companies Inc. Aegis Capital maintained it with "Buy" rating and $52 target in Wednesday, January 6 report. The stock of Williams Companies Inc (NYSE:WMB) earned "Market Perform" rating by Wells Fargo on Thursday, September 10. The firm earned "Buy" rating on Friday, April 7 by Citigroup. The firm earned "Neutral" rating on Wednesday, February 15 by Goldman Sachs. Jefferies upgraded the stock to "Buy" rating in Friday, December 18 report. The rating was maintained by JP Morgan on Tuesday, August 25 with "Neutral". Acorda Therapeutics Inc (NASDAQ:ACOR) has declined 40.68% since June 15, 2016 and is downtrending.'s news article titled: "Biotech Stocks on Investors' Radar - Achillion Pharma, Acorda Therapeutics ..." with publication date: May 26, 2017 was also an interesting one. Timmermans Ted T had sold 1,000 shares worth $30,725 on Tuesday, May 16. Its up 0.10, from 0.89 in 2016Q3. It is negative, as 48 investors sold WMB shares while 217 reduced holdings. Quantbot Ltd Partnership reported 14,604 shares stake. The Director now owns $0 of the stock according to the SEC filing.

Gogo Inc. (NasdaqGS:GOGO) has a current MF Rank of 11090. Royal Commercial Bank Of Scotland Grp Public Limited Com holds 0.08% of its portfolio in Williams Companies Inc (NYSE:WMB) for 9,765 shares. Raymond James Fincl Advsrs Incorporated invested in 0.09% or 196,897 shares. Float is the number of shares available for trading of a particular stock. 8,937 were accumulated by Paloma Mgmt. Geode Cap Management Lc reported 407,794 shares. Bokf Na holds 0.31% or 303,303 shares. Putnam Invests stated it has 145,399 shares.

Analysts await Williams Companies Inc (NYSE:WMB) to report earnings on August, 7. Next quarter's EPS is forecasted to be $0.71 and the next full year EPS is projected to be $1.05. WMB's profit will be $129.93 million for 44.64 P/E if the $0.16 EPS becomes a reality. During the same period in the prior year, the company posted $0.28 earnings per share. 1 is equivalent to a buy rating, 3 a hold rating, and 5 a sell rating. Therefore 60% are positive. Acorda Therapeutics has a 12 month low of $13.60 and a 12 month high of $33.00. State Board Of Administration Of Florida Retirement Systems reported 0% in Acorda Therapeutics Inc (NASDAQ:ACOR). On Wednesday, January 6 the stock rating was maintained by Aegis Capital with "Buy". Analysts have placed a $27.86 price target on Acorda Therapeutics, Inc., suggesting a 62.92% gain from recent close. 25,919 are held by Sg Americas Secs Ltd Company. The firm has "Buy" rating by Stifel Nicolaus given on Tuesday, August 25. Goldman Sachs upgraded the stock to "Neutral" rating in Wednesday, February 15 report.

Investors sentiment increased to 0.99 in Q4 2016. Cubist Systematic Strategies Ltd Liability Corp has invested 0.01% in Acorda Therapeutics Inc (NASDAQ:ACOR). 25 funds opened positions while 47 raised stakes. Millennium Mngmt holds 491,464 shares. Point72 Asia (Hong Kong) owns 667 shares. 596,440 are owned by Price T Rowe Associate Md. Manufacturers Life Insurance Communications The invested in 0% or 30,133 shares. Renaissance Technology Ltd Liability Com holds 0.01% of its portfolio in Acorda Therapeutics Inc (NASDAQ:ACOR) for 385,400 shares. Nationwide Fund Advisors reported 110,986 shares.

Here is the rundown on market activity for Acorda Therapeutics, Inc. (NASDAQ:ACOR) during the first quarter, Holdings Channel reports. 76,200 were reported by Swiss National Bank & Trust. AQR Capital Management LLC boosted its position in Acorda Therapeutics by 10.2% in the fourth quarter. (NASDAQ:AKAO) by 4.48 million shares to 4.58M shares, valued at $59.66 million in 2016Q4, according to the filing. 3,017 shares were sold by Greene Barry E, worth $58,113. The insider LAWRENCE DAVID sold $1.41 million. The insider Wasman Jane sold 54,536 shares worth $1.22M. On average, equities analysts expect that Acorda Therapeutics, Inc. will post $1.98 earnings per share for the current fiscal year. During the same period in the prior year, the company posted $0.28 EPS. SECOR Capital Advisors LP purchased a new stake in shares of Acorda Therapeutics during the third quarter worth $274,000.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

D'autres rapports CampDesrEcrues

Discuter de cet article